Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: A prospective study in 154 consecutive patients
- 9 September 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (9) , 2931-2941
- https://doi.org/10.1002/art.20476
Abstract
Objective To explore prospectively the value of synovial histopathology in comparison with the value of classic parameters for diagnostic classification of spondylarthropathy (SpA) and rheumatoid arthritis (RA) in patients with an atypical disease presentation. Methods Synovial biopsy samples were obtained from 154 consecutive patients presenting for diagnostic evaluation; 67 patients fulfilled the classification criteria for RA, SpA, or other well‐defined disease at the time of arthroscopy (cohort 1), and an additional 53 patients were classified after a full diagnostic reevaluation at 6 months (cohort 2). Synovial parameters with diagnostic value were identified in cohort 1 and were compared prospectively with classic diagnostic parameters in cohort 2. Results Staining with anticitrulline, staining with monoclonal antibody 12A (recognizing HLA–DR shared epitope–human cartilage glycoprotein 39263–275 complexes), and crystal deposition had positive predictive values (PPVs) for diagnosis of >90% in patients with an atypical disease presentation (cohort 2). Using these 3 parameters, a diagnosis was predicted by synovial histopathology in 39.6% of cohort 2 patients and turned out to be correct in 90.5% of these patients at 6 months of followup. Using a multiparameter model rather than single histopathologic parameters, even better results were obtained, with a diagnostic prediction in 79.2% of samples and a PPV of 81.0%. In comparison, a similar multiparameter model using classic diagnostic criteria rather than synovial histopathology performed poorly in cohort 2; the sensitivity was 56.6% and the PPV was 73.3%, with an inferior capacity to predict SpA. Especially for the presence of crystals and anticitrulline staining, the analysis of synovial tissue had a clear added value to the analysis of synovial fluid or serum in patients with an atypical presentation. Conclusion This proof‐of‐concept study indicates that synovial histopathology can contribute to the multiparametric diagnostic classification of inflammatory arthritis in patients with an atypical presentation.Keywords
This publication has 29 references indexed in Scilit:
- Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort studyArthritis & Rheumatism, 2004
- Detection of major histocompatibility complex/human cartilage gp‐39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic markerArthritis & Rheumatism, 2004
- ReplyArthritis & Rheumatism, 2002
- Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomesArthritis & Rheumatism, 2002
- Criteria for early rheumatoid arthritis: From Bayes' law revisited to new thoughts on pathogenesisArthritis & Rheumatism, 2002
- Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathyThe Journal of Pathology, 2002
- Synovial biopsy in arthritis research: five years of concerted European collaborationAnnals of the Rheumatic Diseases, 2000
- Early aggressive DMARD therapy: The key to slowing disease progression in rheumatoid arthritisScandinavian Journal of Rheumatology, 1999
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- A four year follow‐up of suspected rheumatoid arthritis: The Tecumseh, Michigan, community health studyArthritis & Rheumatism, 1969